Breast Cancer Trial, Recruiting NCT07146295 Sponsor: Isabelle Henskens Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07146295
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with either DCIS (a very early form of breast cancer) or invasive breast cancer, confirmed by a biopsy
  • People whose lymph nodes under the arm appear to be unaffected by cancer, as confirmed by an ultrasound scan before surgery
  • People who are already scheduled for breast cancer surgery that includes a sentinel lymph node procedure through an incision in the armpit area

Who may not be able to join:

  • People who are scheduled for a combined MARI procedure (confirm with trial site)
  • People with a known allergy to Indocyanine Green (a dye used in medical procedures), intravenous contrast agents, or iodine
  • People who have previously had lymph nodes removed from the armpit area
  • People who have an overactive thyroid gland or thyroid cancer
  • People who are currently pregnant or breastfeeding
  • People who are unable or unwilling to provide written informed consent as required by the trial's governing guidelines and local regulations

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Annemiek Doeksen, MD, PhD, St. Antonius Hospital

Phone: +31883202902

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Isabelle Henskens
Registry
ClinicalTrials.gov
Start date
18 April 2025
Est. completion
1 July 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Adoption of ICG for sentinel lymph node biopsy (SLNB)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov